Trials / Completed
CompletedNCT01156844
Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Repeated-dose Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Three Different Dosing Regimens of Inhaled Indacaterol Maleate in Patients With Persistent Asthma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 191 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indacaterol | Indacaterol inhaled via Concept1, a single dose dry powder inhaler (SDDPI) for 16 days. Dosage and frequency varied according to randomization scheme. |
| DRUG | Placebo to Indacaterol | Placebo inhaled via Concept1, a SDDPI. Frequency varied according to randomization scheme. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-07-01
- First posted
- 2010-07-05
- Last updated
- 2011-08-17
- Results posted
- 2011-08-17
Locations
30 sites across 6 countries: United States, France, Germany, Jordan, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT01156844. Inclusion in this directory is not an endorsement.